Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Alzheimer Disease
  • Cognitive Decline
  • Dementia
  • Mild Cognitive Impairment
Type
Interventional
Phase
Not Applicable
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Participants are randomly allocated to either the intervention or control group at the beginning of the studyMasking: Double (Investigator, Outcomes Assessor)Masking Description: All study investigators that collect or analyze data are blinded to the group assignment for all participants.Primary Purpose: Prevention

Participation Requirements

Age
Between 45 years and 75 years
Gender
Both males and females

Description

Alzheimer's Disease (AD) is expected to affect 131 million people worldwide by 2050, but as many as 40% of these cases may be prevented by targeting modifiable risk factors such as diet, physical activity, cognitive engagement, and smoking. Neurotrack Technologies, Inc. will test the efficacy of a d...

Alzheimer's Disease (AD) is expected to affect 131 million people worldwide by 2050, but as many as 40% of these cases may be prevented by targeting modifiable risk factors such as diet, physical activity, cognitive engagement, and smoking. Neurotrack Technologies, Inc. will test the efficacy of a digital multi-domain lifestyle intervention with health coaching for cognitive health designed to change behaviors associated with increased risk for AD. This digital intervention addresses the challenge of scaling effective multi-domain lifestyle interventions for cognitive health and has the potential to improve risk behaviors, thereby reducing and/or delaying cognitive decline in older adults at risk for AD.

Tracking Information

NCT #
NCT04559789
Collaborators
  • National Institute on Aging (NIA)
  • University of Arkansas
Investigators
Principal Investigator: Jordan Glenn, PhD Neurotrack Technologies, Inc.